⌘K

Home/Filings/4/0001209191-23-002496

4//SEC Filing

Crowley John J 4

Accession 0001209191-23-002496

CIK 0001805890other

View on SEC.gov Company Profile

Filed

Jan 8, 7:00 PM ET

Accepted

Jan 9, 6:44 AM ET

Size

5.3 KB

Accession

0001209191-23-002496

Insider Transaction Report

Form 4

Period: 2023-01-05

Fusion Pharmaceuticals Inc.FUSN

Chief Financial Officer

Transactions

Award
Stock Option (Right to Buy)
2023-01-05+250,000→ 250,000 total
Exercise: $3.75Exp: 2033-01-04→ Common Stock (250,000 underlying)

Footnotes (1)

[F1]This option vests in 48 equal monthly installments beginning on February 5, 2023.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Fusion Pharmaceuticals Inc.

CIK 0001805890

Entity typeother

Related Parties

1

filerCIK 0001587972

Filing Metadata

Form type: 4
Filed: Jan 8, 7:00 PM ET
Accepted: Jan 9, 6:44 AM ET
Size: 5.3 KB

View on SEC.gov